Company Filing History:
Years Active: 2006-2016
Title: Albertus Wernerus Wognum: Innovator in Cell Assays and Antibody Complexes
Introduction
Albertus Wernerus Wognum is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of cell biology and immunology, holding three patents that reflect his innovative approach to scientific challenges.
Latest Patents
Wognum's latest patents include a method for a shorter colony-forming cell assay. This method allows for the determination of the frequency and proliferative potential of progenitor cells in a starting cell preparation. The process involves culturing the cell preparation for 5-10 days in a culture medium containing FLT-3 Ligand and Thrombopoietin, followed by detecting and enumerating the colonies. This method is particularly useful for predicting and evaluating the suitability of grafts for transplantation. Another significant patent involves tetrameric antibody complexes designed to block non-specific labeling of antigens in immunological assays. This method reduces non-specific binding reactions, enhancing the accuracy of immunological tests.
Career Highlights
Wognum is currently associated with Stemcell Technologies Inc., a company known for its advancements in stem cell research and technology. His work has contributed to the development of innovative solutions in the field, particularly in improving the efficiency of cell assays and immunological assays.
Collaborations
Wognum has collaborated with esteemed colleagues such as Peter Michael Lansdorp and Ning Yuan. These collaborations have further enriched his research and development efforts, leading to impactful innovations in the scientific community.
Conclusion
Albertus Wernerus Wognum's contributions to cell biology and immunology through his patents and collaborations highlight his role as a significant innovator in his field. His work continues to influence advancements in medical research and applications.